Efficacy of INM004 in Children With STEC-HUS

NCT06389474 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Hemolytic-Uremic Syndrome

Interventions

BIOLOGICAL: INM004
OTHER: Placebo

Sponsor

Inmunova S.A.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]